Cell and gene therapies in cardiovascular disease with special focus on the no option patient

Current Gene Therapy

Volumn 6, Issue 6, 2006, Pages 609-623

  Staudacher, Dawid L ^a   Flugelman, Moshe Y ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Angiogenesis; Cell theraphy; Clinical trials; Gene theraphy; Myocardial regeneration; Stem cells

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 4; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LIPOSOME; OLIGONUCLEOTIDE; PLASMID DNA; TRANSCRIPTION FACTOR E2F; VASCULOTROPIN 121; VASCULOTROPIN 165; VASCULOTROPIN C;

ADENOVIRUS VECTOR; ANGIOGENESIS; ARTERY OCCLUSION; CARDIOVASCULAR DISEASE; CELL TYPE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG TREATMENT FAILURE; FOLLOW UP; GENE DELIVERY SYSTEM; GENE THERAPY; GENE TRANSFER; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPERTENSION; LENTIVIRUS VECTOR; LIFESTYLE; LONGEVITY; MORBIDITY; MORTALITY; MUSCLE DEVELOPMENT; MUSCLE INJURY; MYOBLAST; NONHUMAN; PARACRINE SIGNALING; PARVOVIRUS VECTOR; RETROVIRUS VECTOR; REVIEW; SAFETY; SOMATIC CELL; STEM CELL TRANSPLANTATION; TISSUE REGENERATION;

CARDIOVASCULAR DISEASES; CLINICAL TRIALS; GENE THERAPY; GENETIC VECTORS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; REGENERATION; SAFETY; TRANSPLANTS;

EID: 33845429704     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652306779010705     Document Type: Review

References (163)

1. Abbott, J. D., Huang, Y., Liu, D., Hickey, R., Krause, D. S., and Giordano, F. J. (2004): Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110, 3300-5.
2. Abraham, M. R., Henrikson, C. A., Tung, L., Chang, M. G., Aon, M., Xue, T., Li, R. A., B, O. R., and Marban, E. (2005): Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ. Res. 97, 159-67.
3. AHA (2005): International Cardiovascular Disease Statistics, American Heart Association.
4. Aicher, A., Brenner, W., Zuhayra, M., Badorff, C., Massoudi, S., Assmus, B., Eckey, T., Henze, E., Zeiher, A. M., and Dimmeler, S. (2003): Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 107, 2134-9.
5. Akhter, S. A., Skaer, C. A., Kypson, A. P., McDonald, P. H., Peppel, K. C., Glower, D. D., Lefkowitz, R. J., and Koch, W. J. (1997): Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. Proc. Natl. Acad. Sci. USA 94, 12100-5.
6. Alexander, J. H., Hafley, G., Harrington, R. A., Peterson, E. D., Ferguson, T. B., Jr., Lorenz, T. J., Goyal, A., Gibson, M., Mack, M. J., Gennevois, D., Califf, R. M., and Kouchoukos, N. T. (2005): Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA 294, 2446-54.
7. Amado, L. C., Saliaris, A. P., Schuleri, K. H., St John, M., Xie, J. S., Cattaneo, S., Durand, D. J., Fitton, T., Kuang, J. Q., Stewart, G., Lehrke, S., Baumgartner, W. W., Martin, B. J., Heldman, A. W., and Hare, J. M. (2005): Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl. Acad. Sci. USA 102, 11474-9.
8. Anwer, K., Kao, G., Rolland, A., Driessen, W. H., and Sullivan, S. M. (2004): Peptide-mediated gene transfer of cationic lipid/plasmid DNA complexes to endothelial cells. J. Drug Target 12, 215-21.
9. Arsic, N., Zentilin, L., Zacchigna, S., Santoro, D., Stanta, G., Salvi, A., Sinagra, G., and Giacca, M. (2003): Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. Mol. Ther 7, 450-9.
10. Asahara, T., and Kawamoto, A. (2004): Endothelial progenitor cells for postnatal vasculogenesis. Am. J. Physiol. Cell Physiol. 287, C572-9.
11. Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M., and Isner, J. M. (1999): Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85, 221-8.
12. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., and Isner, J. M. (1997): Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-7.
13. Askari, A. T., Unzek, S., Popovic, Z. B., Goldman, C. K., Forudi, F., Kiedrowski, M., Rovner, A., Ellis, S. G., Thomas, J. D., DiCorleto, P. E., Topol, E. J., and Penn, M. S. (2003): Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet. 362, 697-703.
14. Askenasy, N., Yolcu, E. S., Yaniv, I., and Shirwan, H. (2005): Induction of tolerance using Fas ligand: a double-edged immunomodulator. Blood 105, 1396-404.
15. Barbash, I. M., Chouraqui, P., Baron, J., Feinberg, M. S., Etzion, S., Tessone, A., Miller, L., Guetta, E., Zipori, D., Kedes, L. H., Kloner, R. A., and Leor, J. (2003): Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108, 863-8.
16. Bartunek, J., Vanderheyden, M., Vandekerckhove, B., Mansour, S., De Bruyne, B., De Bondt, P., Van Haute, I., Lootens, N., Heyndrickx, G., and Wijns, W. (2005): Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 112, 1178-83.
17. Baumgartner, I., Pieczek, A., Manor, O., Blair, R., Kearney, M., Walsh, K., and Isner, J. M. (1998): Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97, 1114-23.
18. Beltrami, A. P., Urbanek, K., Kajstura, J., Yan, S. M., Finato, N., Bussani, R., Nadal-Ginard, B., Silvestri, F., Leri, A., Beltrami, C. A., and Anversa, P. (2001): Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med. 344, 1750-7.
19. Beltran, A. (2006): Adipose-Derived Stem Cells Improved Left Ventricle Wall Thickness and Capillary Density in Pigs Following Myocardial Infarction in Pre-Clinical Study. 55th Annual Meeting of the American College of Cardiology (ACC).
20. Britten, M. B., Abolmaali, N. D., Assmus, B., Lehmann, R., Honold, J., Schmitt, J., Vogl, T. J., Martin, H., Schachinger, V., Dimmeler, S., and Zeiher, A. M. (2003): Infaret remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCAREAMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 108, 2212-8.
21. Brody, S. L., and Crystal, R. G. (1994): Adenovirus-mediated in. vivo gene transfer. Ann. N. Y. Acad. Sci. USA 716, 90-101; discussion 101-3.
22. Buschmann, I., and Schaper, W. (2000): The pathophysiology of the collateral circulation (arteriogenesis). J. Pathol. 190, 338-42.
23. Chen, L. G., Wang, Z. R., Wan, C. M., Chao, L., Chao, J., and Xing, H. Y. (2004a): Encapsulated transgene cells attenuate hypertension, cardiac hypertrophy and enhance renal function in Goldblatt hypertensive rats. J. Gene Med. 6, 786-97.
24. Chen, M., Fan, Z. C., Liu, X. J., Deng, J. L., Zhang, L., Rao, L., Yang, Q., and Huang, D. J. (2006): Effects of autologous stem cell transplantation on ventricular electrophysiology in doxorubicin-induced heart failure. Cell Biol. Int. 30, 576-82.
25. Chen, S. L., Fang, W. W., Ye, F., Liu, Y. H., Qian, J., Shan, S. J., Zhang, J. J., Chunhua, R. Z., Liao, L. M., Lin, S., and Sun, J. P. (2004b): Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol. 94, 92-5.
26. Cittadini, A., Monti, M. G., Iaccarino, G., Di Rella, F., Tsichlis, P. N., Di Gianni, A., Stromer, H., Sorriento, D., Peschle, C., Trimarco, B., Sacca, L., and Condorelli, G. (2006): Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling. Gene Ther. 13, 8-19.
27. Conte, M. S., Bandyk, D. F., Clowes, A. W., Moneta, G. L., Seely, L., Lorenz, T. J., Namini, H., Hamdan, A. D., Roddy, S. P., Belkin, M., Berceli, S. A., DeMasi, R. J., Samson, R. H., and Berman, S. S. (2006): Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J. Vasc. Surg. 43, 742-751; discussion 751.
28. Corporation, G. (2005): Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients with Intermittent Claudication, Genzyme Corporation, Cambridge, MA 02142.
29. Cosset, F. L., Takeuchi, Y., Battini, J. L., Weiss, R. A., and Collins, M. K. (1995): High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69, 7430-6.
30. Dai, W., Hale, S. L., Martin, B. J., Kuang, J. Q., Dow, J. S., Wold, L. E., and Kloner, R. A. (2005): Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 112, 214-23.
31. Dass, C. R. (2004): Lipoplex-mediated delivery of nucleic acids: factors affecting in. vivo transfection. J. Mol. Med. 82, 579-91.
32. Deb, A., Wang, S., Skelding, K. A., Miller, D., Simper, D., and Caplice, N. M. (2003): Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients. Circulation 107, 1247-9.
33. Deten, A., Volz, H. C., Clamors, S., Leiblein, S., Briest, W., Marx, G., and Zimmer, H. G. (2005): Hematopoietic stem cells do not repair the infarcted mouse heart. Cardiovasc. Res. 65, 52-63.
34. Dib, N., Michler, R. E., Pagani, F. D., Wright, S., Kereiakes, D. J., Lengerich, R., Binkley, P., Buchele, D., Anand, I., Swingen, C., Di Carli, M. F., Thomas, J. D., Jaber, W. A., Opie, S. R., Campbell, A., McCarthy, P., Yeager, M., Dilsizian, V., Griffith, B. P., Korn, R., Kreuger, S. K., Ghazoul, M., MacLellan, W. R., Fonarow, G., Eisen, H. J., Dinsmore, J., and Diethrich, E. (2005): Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 112, 1748-55.
35. Dimmeler, S., Aicher, A., Vasa, M., Mildner-Rihm, C., Adler, K., Tiemann, M., Rutten, H., Fichtlscherer, S., Martin, H., and Zeiher, A. M. (2001): HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI3-kinase/Akt pathway. J. Clin. Invest. 108, 391-7.
36. Dohmann, H. F., Perin, E. C., Takiya, C. M., Silva, G. V., Silva, S. A., Sousa, A. L., Mesquita, C. T., Rossi, M. I., Pascarelli, B. M., Assis, I. M., Dutra, H. S., Assad, J. A., Castello-Branco, R. V., Drummond, C., Dohmann, H. J., Willerson, J. T., and Borojevic, R. (2005): Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings. Circulation 112, 521-6.
37. Ehsan, A., Mann, M. J., Dell'Acqua, G., and Dzau, V. J. (2001): Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy. J. Thorac. Cardiovasc. Surg. 121, 714-22.
38. Fazel, S., Cimini, M., Chen, L., Li, S., Angoulvant, D., Fedak, P., Verma, S., Weisel, R. D., Keating, A., and Li, R. K. (2006): Cardioprotective c-kit cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J. Clin. Invest. 116, 1865-1877.
39. Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M., and Danielsen, M. (1987): Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84, 7413-7.
40. Felgner, P. L., Tsai, Y. J., Sukhu, L., Wheeler, C. J., Manthorpe, M., Marshall, J., and Cheng, S. H. (1995): Improved cationic lipid formulations for in. vivo gene therapy. Ann. N. Y. Acad. Sci. 772, 126-39.
41. Fernandes, S., Amirault, J. C., Lande, G., Nguyen, J. M., Forest, V., Bignolais, O., Lamirault, G., Heudes, D., Orsonneau, J. L., Heymann, M. F., Charpentier, F., and Lemarchand, P. (2006): Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias. Cardiovasc. Res. 69, 348-58.
42. Fernandez-Aviles, F., San Roman, J. A., Garcia-Frade, J., Fernandez, M. E., Penarrubia, M. J., de la Fuente, L., Gomez-Bueno, M., Cantalapiedra, A., Fernandez, J., Gutierrez, O., Sanchez, P. L., Hernandez, C., Sanz, R., Garcia-Sancho, J., and Sanchez, A. (2004): Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ. Res. 95, 742-8.
43. Ferrarini, M., Arsic, N., Recchia, F. A., Zentilin, L., Zacchigna, S., Xu, X., Linke, A., Giacca, M., and Hintze, T. H. (2006): Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs. Circ. Res. 98, 954-61.
44. Fischer, L., Preis, M., Weisz, A., Koren, B., Lewis, B., and Flugelman, M. (2002): Viral Vectors for Vascular Gene Therapy. Exp. Clin. Cardiol. 106-112.
45. Flugelman, M. Y. (1995): Inhibition of intravascular thrombosis and vascular smooth muscle cell proliferation by gene therapy. Thromb. Haemost. 74, 406-10.
46. Flugelman, M. Y., Jaklitsch, M. T., Newman, K. D., Casscells, W., Bratthauer, G. L., and Dichek, D. A. (1992a): Low level in vivo gene transfer into the arterial wall through a perforated balloon catheter. Circulation 85, 1110-7.
47. Flugelman, M. Y., Virmani, R., Leon, M. B., Bowman, R. L., and Dichek, D. A. (1992b): Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to flow in vitro. Circ. Res. 70, 348-54.
48. Fraser, J. K., Schreiber, R., Strem, B., Zhu, M., Alfonso, Z., Wulur, I., and Hedrick, M. H. (2006): Plasticity of human adipose stem cells toward endothelial cells and cardiomyocytes. Nat. Clin. Pract. Cardiovasc. Med. 3 Suppl 1, S33-7.
49. Freyman, T., Polin, G., Osman, H., Crary, J., Lu, M., Cheng, L., Palasis, M., and Wilensky, R. L. (2006): A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur. Heart J. 27, 1114-22.
50. Fuchs, S., Baffour, R., Zhou, Y. F., Shou, M., Pierre, A., Tio, F. O., Weissman, N. J., Leon, M. B., Epstein, S. E., and Kornowski, R. (2001): Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J. Am. Coll. Cardiol. 37, 1726-32.
51. Genetics, C. (2004): GENASIS (Genetic Angiogenic Stimulation Investigational Study), www.Clinicaltrials.gov.
52. George, J., Afek, A., Abashidze, A., Shmilovich, H., Deutsch, V., Kopolovich, J., Miller, H., and Keren, G. (2005): Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein e knockout mice. Arterioscler Thromb. Vasc. Biol. 25, 2636-.41.
53. Gepstein, L., Feld, Y., and Yankelson, L. (2004): Somatic gene and cell therapy strategies for the treatment of cardiac arrhythmias. Am. J. Physiol. Heart Circ. Physiol. 286, H815-22.
54. Grines, C. L., Watkins, M. W., Mahmarian, J. J., Iskandrian, A. E., Rade, J. J., Marrott, P., Pratt, C., and Kleiman, N. (2003): A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J. Am. Coll. Cardiol. 42, 1339-47.
55. Groh, I., Beilner, J., Blomer, U., Schmiedl, A., Schmidt-Richter, I., Kruse, M. L., Haverich, A., and Martin, U. (2006): No evidence of transdifferentiation of human endothelial progenitor cells into cardiomyocytes after coculture with neonatal rat cardiomyocytes. Circulation 113, 1326-34.
56. Gyurko, R., Wielbo, D., and Phillips, M. I. (1993): Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Regul. Pept. 49, 167-74.
57. Hagege, A. A., Marolleau, J. P., Vilquin, J. T., Alheritiere, A., Peyrard, S., Duboc, D., Abergel, E., Messas, E., Mousseaux, E., Schwartz, K., Desnos, M., and Menasche, P. (2006): Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation 114, 1108-13.
58. Hayashi, K., Banno, H., Kadomatsu, K., Takei, Y., Komori, K., and Muramatsu, T. (2005): Antisense oligodeoxyribonucleotide as to the growth factor midkine suppresses neointima formation induced by balloon injury. Am. J. Physiol. Heart. Circ. Physiol. 288, H2203-9.
59. Hedman, M., Hartikainen, J., Syvanne, M., Stjernvall, J., Hedman, A., Kivela, A., Vanninen, E., Mussalo, H., Kauppila, E., Simula, S., Narvanen, O., Rantala, A., Peuhkurinen, K., Nieminen, M. S., Laakso, M., and Yla-Herttuala, S. (2003): Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 107, 2677-83.
60. Henry, T. (2004): Gene Therapy Did Not Increase Exercise Duration at Interim Analysis. Transcatheter Cardiovascular Therapeutics (TCT) meeting 2004.
61. Henry, T. D., Annex, B. H., McKendall, G. R., Azrin, M. A., Lopez, J. J., Giordano, F. J., Shah, P. K., Willerson, J. T., Benza, R. L., Berman, D. S., Gibson, C. M., Bajamonde, A., Rundle, A. C., Fine, J., and McCluskey, E. R. (2003): The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation 107, 1359-65.
62. Hocht-Zeisberg, E., Kahnert, H., Guan, K., Wulf, G., Hemmerlein, B., Schlott, T., Tenderich, G., Korfer, R., Raute-Kreinsen, U., and Hasenfuss, G. (2004): Cellular repopulation of myocardial infarction in patients with sex-mismatched heart transplantation. Eur. Heart J. 25, 749-58.
63. Hou, D., Youssef, E. A., Brinton, T. J., Zhang, P., Rogers, P., Price, E. T., Yeung, A. C., Johnstone, B. H., Yock, P. G., and March, K. L. (2005): Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 112, 1150-6.
64. Ince, H., Petzsch, M., Kleine, H. D., Schmidt, H., Rehders, T., Korber, T., Schumichen, C., Freund, M., and Nienaber, C. A. (2005): Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation 112, 3097-106.
65. Ingram, D. A., Mead, L. E., Moore, D. B., Woodard, W., Fenoglio, A., and Yoder, M. C. (2005): Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 105, 2783-6.
66. Isner, J. M., Pieczek, A., Schainfeld, R., Blair, R., Haley, L., Asahara, T., Rosenfield, K., Razvi, S., Walsh, K., and Symes, J. F. (1996): Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet. 348, 370-4.
67. Isner, J. M., Vale, P. R., Symes, J. F., and Losordo, D. W. (2001): Assessment of risks associated with cardiovascular gene therapy in human subjects. Circ. Res. 89, 389-400.
68. Iwanaga, K., Takano, H., Ohtsuka, M., Hasegawa, H., Zou, Y., Qin, Y., Odaka, K., Hiroshima, K., Tadokoro, H., and Komuro, I. (2004): Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine. Biochem. Biophys. Res. Commun. 325, 1353-9.
69. Janssens, S., Dubois, C., Bogaert, J., Theunissen, K., Deroose, C., Desmet, W., Kalantzi, M., Herbots, L., Sinnaeve, P., Dens, J., Maertens, J., Rademakers, F., Dymarkowski, S., Gheysens, O., Van Cleemput, J., Bormans, G., Nuyts, J., Belmans, A., Mortelmans, L., Boogaerts, M., and Van de Werf, F. (2006): Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367, 113-21.
70. Kalka, C., Masuda, H., Takahashi, T., Kalka-Moll, W. M., Silver, M., Kearney, M., Li, T., Isner, J. M., and Asahara, T. (2000): Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA 97, 3422-7.
71. Kang, H. J., Kim, H. S., Zhang, S. Y., Park, K. W., Cho, H. J., Koo, B. K., Kim, Y. J., Soo Lee, D., Sohn, D. W., Han, K. S., Oh, B. H., Lee, M. M., and Park, Y. B. (2004): Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363, 751-6.
72. Kang, H. J., Lee, H. Y., Na, S. H., Chang, S. A., Park, K. W., Kim, H. K., Kim, S. Y., Chang, H. J., Lee, W., Kang, W. J., Koo, B. K., Kim, Y. J., Lee, D. S., Sohn, D. W., Han, K. S., Oh, B. H., Park, Y. B., and Kim, H. S. (2006): Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation 114, 1145-51.
73. Kanki-Horimoto, S., Horimoto, H., Mieno, S., Kishida, K., Watanabe, F., Furuya, E., and Katsumata, T. (2006): Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension. Circulation 114, 1181-5.
74. Kastrup, J., Jorgensen, E., Ruck, A., Tagil, K., Glogar, D., Ruzyllo, W., Botker, H. E., Dudek, D., Drvota, V., Hesse, B., Thuesen, L., Blomberg, P., Gyongyosi, M., and Sylven, C. (2005): Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial. J. Am. Coll. Cardiol. 45, 982-8.
75. Kastrupa, J., Jørgensena, E., Drvotab, V., Thuesend, L., Bøtkerd, H. E., Gyöngyösie, M., Glogare, D., Rückb, A., Bin Islamc, K., Sylvénb, C., and Group, a. t. E. O. (2001): Intramyocardial Injection of Genes with a Novel Percutaneous Technique: Initial Safety Data of the Euroinject One Study. Heart Drug 2001;1:299-304 (DOI:10.1159/000048979).
76. Katsube, K., Bishop, A. T., and Friedrich, P. F. (2004): Transduction of rabbit saphenous artery: a comparison of naked DNA, liposome complexes, and adenovirus vectors. J. Orthop. Res. 22, 1290-5.
77. Kawamoto, A., Gwon, H. C., Iwaguro, H., Yamaguchi, J. I., Uchida, S., Masuda, H., Silver, M., Ma, H., Kearney, M., Isner, J. M., and Asahara, T. (2001): Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103, 634-7.
78. Kimura, B., Mohuczy, D., Tang, X., and Phillips, M. I. (2001): Attenuation of hypertension and heart hypertrophy by adeno-associated virus delivering angiotensinogen antisense. Hypertension 37, 376-80.
79. Kobayashi, K., Kondo, T., Inoue, N., Aoki, M., Mizuno, M., Komori, K., Yoshida, J., and Murohara, T. (2006): Combination of in vivo angiopoietin-1 gene transfer and autologous bone marrow cell implantation for functional therapeutic angiogenesis. Arterioscler. Thromb. Vasc. Biol. 26, 1465-72.
80. Kocher, A. A., Schuster, M. D., Szabolcs, M. J., Takuma, S., Burkhoff, D., Wang, J., Homma, S., Edwards, N. M., and Itescu, S. (2001): Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med 7, 430-6.
81. Koren, B., Weisz, A., Fischer, L., Gluzman, Z., Preis, M., Avramovitch, N., Cohen, T., Cosset, F. L., Lewis, B. S., and Flugelman, M. Y. (2006): Efficient transduction and seeding of human endothelial cells onto metallic stents using bicistronic pseudo-typed retroviral vectors encoding vascular endothelial growth factor. Cardiovas. Revascularization. Med. 7, 173-178.
82. Kuethe, F., Richartz, B. M., Sayer, H. G., Kasper, C., Werner, G. S., Hofken, K., and Figulla, H. R. (2004): Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions. Int. J. Cardiol. 97, 123-7.
83. Laham, R. J., Simons, M., and Sellke, F. (2001): Gene transfer for angiogenesis in coronary artery disease. Annu. Rev. Med. 52, 485-502.
84. Laugwitz, K. L., Moretti, A., Weig, H. J., Gillitzer, A., Pinkernell, K., Ott, T., Pragst, I., Stadele, C., Seyfarth, M., Schomig, A., and Ungerer, M. (2001): Blocking caspase-activated apoptosis improves contractility in failing myocardium. Hum. Gene Ther. 12, 2051-63.
85. Lehrman, S. (1999): Virus treatment questioned after gene therapy death. Nature 401, 517-8.
86. Lenk, K., Adams, V., Lurz, P., Erbs, S., Linke, A., Gielen, S., Schmidt, A., Scheinert, D., Biamino, G., Emmrich, F., Schuler, G., and Hambrecht, R. (2005): Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia. Eur. Heart J. 26, 1903-9.
87. Levesque, J. P., Hendy, J., Takamatsu, Y., Simmons, P. J., and Bendall, L. J. (2003): Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J. Clin. Invest. 111, 187-96.
88. Li, R. K., Mickle, D. A., Weisel, R. D., Zhang, J., and Mohabeer, M. K. (1996): In vivo survival and function of transplanted rat cardiomyocytes. Circ. Res. 78, 283-8.
89. Lin, K. F., Chao, L., and Chao, J. (1997): Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery. Hypertension 30, 307-13.
90. Mann, M. J., Whittemore, A. D., Donaldson, M. C., Belkin, M., Conte, M. S., Polak, J. F., Orav, E. J., Ehsan, A., Dell'Acqua, G., and Dzau, V. J. (1999): Ex vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. Lancet 354, 1493-8.
91. Matsumoto, R., Omura, T., Yoshiyama, M., Hayashi, T., Inamoto, S., Koh, K. R., Ohta, K., Izumi, Y., Nakamura, Y., Akioka, K., Kitaura, Y., Takeuchi, K., and Yoshikawa, J. (2005): Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 25, 1168-73.
92. Maurice, J. P., Hata, J. A., Shah, A. S., White, D. C., McDonald, P. H., Dolber, P. C., Wilson, K. H., Lefkowitz, R. J., Glower, D. D., and Koch, W. J. (1999): Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery. J. Clin. Invest. 104, 21-9.
93. Menasche, P., Hagege, A. A., Vilquin, J. T., Desnos, M., Abergel, E., Pouzet, B., Bel, A., Sarateanu, S., Scorsin, M., Schwartz, K., Bruneval, P., Benbunan, M., Marolleau, J. P., and Duboc, D. (2003): Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 41, 1078-83.
94. Messina, E., De Angelis, L., Frati, G., Morrone, S., Chimenti, S., Fiordaliso, F., Salio, M., Battaglia, M., Latronico, M. V., Coletta, M., Vivarelli, E., Frati, L., Cossu, G., and Giacomello, A. (2004): Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 95, 911-21.
95. Meyer, G. P., Wollert, K. C., Lotz, J., Steffens, J., Lippolt, P., Fichtner, S., Hecker, H., Schaefer, A., Arseniev, L., Hertenstein, B., Ganser, A., and Drexler, H. (2006): Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113, 1287-94.
96. Mhashilkar, A. M., Doebis, C., Seifert, M., Busch, A., Zani, C., Soo Hoo, J., Nagy, M., Ritter, T., Volk, H. D., and Marasco, W. A. (2002): Intrabody-mediated phenotypic knockout of major histocompatibility complex class I expression in human and monkey cell lines and in primary human keratinocytes. Gene Ther. 9, 307-19.
97. Miake, J., Marban, E., and Nuss, H. B. (2002): Biological pacemaker created by gene transfer. Nature 419, 132-3.
98. Miller, A. D., Miller, D. G., Garcia, J. V., and Lynch, C. M. (1993): Use of retroviral vectors for gene transfer and expression. Methods Enzymol. 217, 581-99.
99. Miller, D. G., Adam, M. A., and Miller, A. D. (1990): Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell Biol. 10, 4239-42.
100. Min, J. Y., Yang, Y., Converso, K. L., Liu, L., Huang, Q., Morgan, J. P., and Xiao, Y. F. (2002): Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J. Appl. Physiol. 92, 288-96.
101. Minami, E., Laflamme, M. A., Saffitz, J. E., and Murry, C. E. (2005): Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation 112, 2951-8.
102. Miyahara, Y., Nagaya, N., Kataoka, M., Yanagawa, B., Tanaka, K., Hao, H., Ishino, K., Ishida, H., Shimizu, T., Kangawa, K., Sano, S., Okano, T., Kitamura, S., and Mori, H. (2006): Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med. 12, 459-65.
103. Murry, C. E., Wiseman, R. W., Schwartz, S. M., and Hauschka, S. D. (1996): Skeletal myoblast transplantation for repair of myocardial necrosis. J. Clin. Invest. 98, 2512-23.
104. Nabel, E. G., Plautz, G., Boyce, F. M., Stanley, J. C., and Nabel, G. J. (1989): Recombinant gene expression in. vivo within endothelial cells of the arterial wall. Science 244, 1342-4.
105. Nabel, E. G., Plautz, G., and Nabel, G. J. (1990): Site-specific gene expression in. vivo by direct gene transfer into the arterial wall. Science 249, 1285-8.
106. Nikol, S. (2006): Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. ACC.06.
107. Orlic, D., Kajstura, J., Chimenti, S., Bodine, D. M., Leri, A., and Anversa, P. (2003): Bone marrow stem cells regenerate infarcted myocardium. Pediatr. Transplant 7 Suppl 3, 86-8.
108. Orlic, D., Kajstura, J., Chimenti, S., Limana, F., Jakoniuk, I., Quaini, F., Nadal-Ginard, B., Bodine, D. M., Leri, A., and Anversa, P. (2001): Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA 98, 10344-9.
109. Pelisek, J., Fuchs, A., Engelmann, M. G., Shimizu, M., Golda, A., Mekkaoui, C., Rolland, P. H., and Nikol, S. (2003): Vascular endothelial growth factor response in porcine coronary and peripheral arteries using nonsurgical occlusion model, local delivery, and liposome-mediated gene transfer. Endothelium 10, 247-55.
110. Penn, M. S. (2006): Stem-cell therapy after acute myocardial infarction: the focus should be on those at risk. Lancet. 367, 87-8.
111. Penny, W. F., and Hammond, H. K. (2004): Clinical use of intracoronary gene transfer of fibroblast growth factor for coronary artery disease. Curr. Gene Ther. 4, 225-30.
112. Preis M, Cohen T, Samatzki Y, Ben Yosef Y, Schneiderman J, Gluzman Z, Koren B, Lewis BS, Shaul Y, and MY, F. (2006): Effects of Fibulin-5 on attachment, adhesion, and proliferation of primary human endothelial cells. Biochem. Biophys. Res. Commun. 348, 1024-33.
113. Quaini, F., Urbanek, K., Beltrami, A. P., Finato, N., Beltrami, C. A., Nadal-Ginard, B., Kajstura, J., Leri, A., and Anversa, P. (2002): Chimerism of the transplanted heart. N. Engl. J. Med. 346, 5-15.
114. Radke, P. W., Griesenbach, U., Kivela, A., Vick, T., Judd, D., Munkonge, F., Willis, S., Geddes, D. M., Yla-Herttuala, S., and Alton, E. W. (2005): Vascular oligonucleotide transfer facilitated by a polymercoated stent. Hum. Gene Ther. 16, 734-40.
115. Rajagopalan, S., Mohler, E. R., 3rd, Lederman, R. J., Mendelsohn, F. O., Saucedo, J. F., Goldman, C. K., Blebea, J., Macko, J., Kessler, P. D., Rasmussen, H. S., and Annex, B. H. (2003): Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 108, 1933-8.
116. Rasmussen, H. S., Rasmussen, C. S., and Macko, J. (2002): VEGF gene therapy for coronary artery disease and peripheral vascular disease. Cardiovasc. Radiat. Med. 3, 114-7.
117. Reinecke, H., Zhang, M., Bartosek, T., and Murry, C. E. (1999): Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 100, 193-202.
118. Ripa, R. S., Jorgensen, E., Wang, Y., Thune, J. J., Nilsson, J. C., Sondergaard, L., Johnsen, H. E., Kober, L., Grande, P., and Kastrup, J. (2006a): Stem Cell Mobilization Induced by Subcutaneous Granulocyte-Colony Stimulating Factor to Improve Cardiac Regeneration After Acute ST-Elevation Myocardial Infarction. Result of the Double-Blind, Randomized, Placebo-Controlled Stem Cells in Myocardial Infarction (STEMMI) Trial. Circulation 113, 1983-92.
119. Ripa, R. S., Wang, Y., Jorgensen, E., Johnsen, H. E., Hesse, B., and Kastrup, J. (2006b): Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease. Eur. Heart J. 27, 1785-92.
120. Risau, W., and Flamme, I. (1995): Vasculogenesis. Annu. Rev. Cell. Dev. Biol. 11, 73-91.
121. Rolling, F., Shen, W. Y., Tabarias, H., Constable, I., Kanagasingam, Y., Barry, C. J., and Rakoczy, P. E. (1999): Evaluation of adeno-associated virus-mediated gene transfer into the rat retina by clinical fluorescence photography. Hum. Gene. Ther. 10, 641-8.
122. Rosen, M. R., Brink, P. R., Cohen, I. S., and Robinson, R. B. (2004): Genes, stem cells and biological pacemakers. Cardiovasc. Res. 64, 12-23.
123. Sakoda, T., Kasahara, N., Hamamori, Y., and Kedes, L. (1999): A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes. J. Mol. Cell Cardiol. 31, 2037-47.
124. Schachinger, V., Assmus, B., Britten, M. B., Honold, J., Lehmann, R.,
125. Schmidt-Lucke, C., Rossig, L., Fichtlscherer, S., Vasa, M., Britten, M., Kamper, U., Dimmeler, S., and Zeiher, A. M. (2005): Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111, 2981-7.
126. Schuster, M. D., Kocher, A. A., Seki, T., Martens, T. P., Xiang, G., Homma, S., and Itescu, S. (2004): Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration. Am. J. Physiol. Heart Circ. Physiol. 287, H525-32.
127. Seiler, C., Pohl, T., Wustmann, K., Hutter, D., Nicolet, P. A., Windecker, S., Eberli, F. R., and Meier, B. (2001): Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation 104, 2012-7.
128. Shimpo, M., Ikeda, U., Maeda, Y., Takahashi, M., Miyashita, H., Mizukami, H., Urabe, M., Kume, A., Takizawa, T., Shibuya, M., Ozawa, K., and Shimada, K. (2002): AAV-mediated VEGF gene transfer into skeletal muscle stimulates angiogenesis and improves blood flow in a rat hindlimb ischemia model. Cardiovasc. Res. 53, 993-1001.
129. Shintani, S., Murohara, T., Ikeda, H., Ueno, T., Sasaki, K., Duan, J., and Imaizumi, T. (2001): Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 103, 897-903.
130. Simons, M., Annex, B. H., Laham, R. J., Kleiman, N., Henry, T., Dauerman, H., Udelson, J. E., Gervino, E. V., Pike, M., Whitehouse, M. J., Moon, T., and Chronos, N. A. (2002): Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 105, 788-93.
131. Skobel, E., Schuh, A., Schwarz, E. R., Liehn, E. A., Franke, A., Breuer, S., Gunther, K., Reffelmann, T., Hanrath, P., and Weber, C. (2004): Transplantation of fetal cardiomyocytes into infarcted rat hearts results in long-term functional improvement. Tissue Eng. 10, 849-64.
132. Soonpaa, M. H., Koh, G. Y., Klug, M. G., and Field, L. J. (1994): Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 264, 98-101.
133. Staudacher, D. L., Preis, M., Lewis, B. S., Grossman, P. M., and Flugelman, M. Y. (2006): Cellular and molecular therapeutic modalities for arterial obstructive syndromes. Pharmacol. Ther. 109, 263-73.
134. Stewart, D. J. (2002): Late-Breaking Clinical Trial Abstracts - A Phase 2, Randomized, Multicenter, 26-Week Study to Assess the Efficacy and Safety of BIOBYPASS (AdGVVEGF121.10) Delivered Through Minimally Invasive Surgery Versus Maximum Medical Treatment in Patients With Severe Angina, Advanced Coronary Artery Disease, and No Options for Revascularization. Circulation 2002;106:2986-a.
135. Strauer, B. E., Brehm, M., Zeus, T., Kostering, M., Hernandez, A., Sorg, R. V., Kogler, G., and Wernet, P. (2002): Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106, 1913-8.
136. Takahashi, M., Li, T. S., Suzuki, R., Kobayashi, T., Ito, H., Ikeda, Y., Matsuzaki, M., and Hamano, K. (2006): Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Am. J. Physiol. Heart Circ. Physiol. 291, H886-93.
137. Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M., Magner, M., Isner, J. M., and Asahara, T. (1999): Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5, 434-8.
138. Tamaki, T., Uchiyama, Y., Okada, Y., Ishikawa, T., Sato, M., Akatsuka, A., and Asahara, T. (2005): Functional recovery of damaged skeletal muscle through synchronized vasculogenesis, myogenesis, and neurogenesis by muscle-derived stem cells. Circulation 112, 2857-66.
139. Tateno, K., Minamino, T., Toko, H., Akazawa, H., Shimizu, N., Takeda, S., Kunieda, T., Miyauchi, H., Oyama, T., Matsuura, K., Nishi, J., Kobayashi, Y., Nagai, T., Kuwabara, Y., Iwakura, Y., Nomura, F., Saito, Y., and Komuro, I. (2006): Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ. Res. 98, 1194-202.
140. Thum, T., Bauersachs, J., Poole-Wilson, P. A., Volk, H. D., and Anker, S. D. (2005): The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J. Am. Coll. Cardiol. 46, 1799-802.
141. Urbanek, K., Torella, D., Sheikh, F., De Angelis, A., Nurzynska, D., Silvestri, F., Beltrami, C. A., Bussani, R., Beltrami, A. P., Quaini, F., Bolli, R., Leri, A., Kajstura, J., and Anversa, P. (2005): Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc. Natl. Acad. Sci. USA. 102, 8692-7.
142. Urbich, C., Aicher, A., Heeschen, C., Dernbach, E., Hofmann, W. K., Zeiher, A. M., and Dimmeler, S. (2005): Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J. Mol. Cell. Cardiol. 39, 733-42.
143. van Royen, N., Piek, J. J., Buschmann, I., Hoefer, I., Voskuil, M., and Schaper, W. (2001): Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. Cardiovasc. Res. 49, 543-53.
144. Vanderheyden, M., Mansour, S., and Bartunek, J. (2005): Accelerated atherosclerosis following intracoronary haematopoietic stem cell administration. Heart 91, 448.
145. Vulliet, P. R., Greeley, M., Halloran, S. M., MacDonald, K. A., and Kittleson, M. D. (2004): Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 363, 783-4.
146. Wang, C., Dobrzynski, E., Chao, J., and Chao, L. (2001a): Adrenomedullin gene delivery attenuates renal damage and cardiac hypertrophy in Goldblatt hypertensive rats. Am. J. Physiol. Renal. Physiol. 280, F964-71.
147. Wang, J. S., Shum-Tim, D., Chedrawy, E., and Chiu, R. C. (2001b): The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. J. Thorac. Cardiovasc. Surg. 122, 699-705.
148. Wang, Y., Haider, H. K., Ahmad, N., Xu, M., Ge, R., and Ashraf, M. (2006): Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair. J. Mol. Cell Cardiol. 40, 736-45.
149. WHO (2004): The world health report 2004, World Health Organization.
150. Wiehe, J. M., Zimmermann, O., Greiner, J., Homann, J. M., Wiesneth, M., Hombach, V., and Torzewski, J. (2005): Labeling of adult stem cells for in. vivo-application in the human heart. Histol. Histopathol. 20, 901-6.
151. Wojakowski, W., Tendera, M., Michalowska, A., Majka, M., Kucia, M., Maslankiewicz, K., Wyderka, R., Ochala, A., and Ratajczak, M. Z. (2004): Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 110, 3213-20.
152. Wollert, K. C., Meyer, G. P., Lotz, J., Ringes-Lichtenberg, S., Lippolt, P., Breidenbach, C., Fichtner, S., Korte, T., Hornig, B., Messinger, D., Arseniev, L., Hertenstein, B., Ganser, A., and Drexler, H. (2004): Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364, 141-8.
153. Woods, N. B., Bottero, V., Schmidt, M., von Kalle, C., and Verma, I. M. (2006): Gene therapy: therapeutic gene causing lymphoma. Nature 440, 1123.
154. Yamamoto, K., Sokabe, T., Watabe, T., Miyazono, K., Yamashita, J. K., Obi, S., Ohura, N., Matsushita, A., Kamiya, A., and Ando, J. (2005): Fluid shear stress induces differentiation of Flk-1-positive embryonic stem cells into vascular endothelial cells in. vitro. Am. J. Physiol. Heart Circ. Physiol. 288, H1915-24.
155. Yamauchi, A., Ito, Y., Morikawa, M., Kobune, M., Huang, J., Sasaki, K., Takahashi, K., Nakamura, K., Dehari, H., Niitsu, Y., Abe, T., and Hamada, H. (2003): Pre-administration of angiopoietin-1 followed by VEGF induces functional and mature vascular formation in a rabbit ischemic model. J. Gene Med. 5, 994-1004.
156. Yang, J., Zhou, W., Zheng, W., Ma, Y., Lin, L., Tang, T., Liu, J., Yu, J., Zhou, X., and Hu, J. (2006): Effects of Myocardial Transplantation of Marrow Mesenchymal Stem Cells Transfected with Vascular Endothelial Growth Factor for the Improvement of Heart Function and Angiogenesis after Myocardial Infarction. Cardiology 107, 17-29.
157. Yau, T. M., Fung, K., Weisel, R. D., Fujii, T., Mickle, D. A., and Li, R. K. (2001): Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation 104, I218-22.
158. Yau, T. M., Kim, C., Li, G., Zhang, Y., Weisel, R. D., and Li, R. K. (2005): Maximizing ventricular function with multimodal cell-based gene therapy. Circulation 112, I123-8.
159. Yeh, E. T., Zhang, S., Wu, H. D., Korbling, M., Willerson, J. T., and Estrov, Z. (2003): Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 108, 2070-3.
160. Yla-Herttuala, S., and Martin, J. F. (2000): Cardiovascular gene therapy. Lancet 355, 213-22.
161. Zhao, C., Wang, P., Xiao, X., Chao, J., Chao, L., Wang, D. W., and Zeldin, D. C. (2003): Gene therapy with human tissue kallikrein reduces hypertension and hyperinsulinemia in fructose-induced hypertensive rats. Hypertension 42, 1026-33.
162. Zimmet, J. M., and Hare, J. M. (2005): Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy. Basic. Res. Cardiol. 100, 471-81.
163. Zohlnhofer, D., Ott, I., Mehilli, J., Schomig, K., Michalk, F., Ibrahim, T., Meisetschlager, G., von Wedel, J., Bollwein, H., Seyfarth, M., Dirschinger, J., Schmitt, C., Schwaiger, M., Kastrati, A., and Schomig, A. (2006): Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 295, 1003-10.